累積罹患率、累積発生率

WordNet

the relative frequency of occurrence of something (同)relative incidence
the striking of a light beam on a surface; "he measured the angle of incidence of the reflected light"

PrepTutorEJDIC

(病気・事件・犯罪などの)発生率,頻度;発生(影響)する範囲 / 投射[角],入射[角]
しだいに増加する,累加する,累積的な

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/08/26 23:20:07」(JST)

wiki en

Cumulative incidence or incidence proportion is a measure of frequency, as in epidemiology, where it is a measure of disease frequency during a period of time. Where the period of time considered is an entire lifetime, the incidence proportion is called lifetime risk.^[1]

Cumulative incidence is defined as the probability that a particular event, such as occurrence of a particular disease, has occurred before a given time.^[2] It is equivalent to the incidence, calculated using a period of time during which all of the individuals in the population are considered to be at risk for the outcome. It is sometimes also referred to as the incidence proportion.

Cumulative incidence is calculated by the number of new cases during a period divided by the number of subjects at risk in the population at the beginning of the study.

It may also be calculated by the incidence rate multiplied by duration:^[3]

References

^ Rychetnik L, Hawe P, Waters E, Barratt A, Frommer M (July 2004). "A glossary for evidence based public health". J Epidemiol Community Health. 58 (7): 538–45. doi:10.1136/jech.2003.011585. PMC 1732833. PMID 15194712.
^ Dodge, Y. (2003). The Oxford Dictionary of Statistical Terms. OUP. ISBN 0-19-920613-9.
^ Bouyer, Jean; Hémon, Denis; Cordier, Sylvaine; Derriennic, Francis; Stücker, Isabelle; Stengel, Bénédicte; Clavel, Jacqueline (2009). Épidemiologie principes et méthodes quantitatives. Paris: Lavoisier.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. プラチナベースの化学療法の神経学的合併症の概要 overview of neurologic complications of platinum based chemotherapy
2. 冠動脈ステント血栓症：発症率および危険因子 coronary artery stent thrombosis incidence and risk factors
3. 脳転移患者の臨床症状、診断、およびマネージメントの概要 overview of the clinical manifestations diagnosis and management of patients with brain metastases
4. 小児および思春期におけるホジキンリンパ腫の概要 overview of hodgkin lymphoma in children and adolescents
5. 非プラチナ製剤ベースの癌化学療法の神経学的合併症の概要 overview of neurologic complications of non platinum cancer chemotherapy

English Journal

Stem cell transplantation outcomes in lymphoblastic lymphoma.

Brammer JE1, Khouri I1, Marin D1, Ledesma C1, Rondon G1, Ciurea SO1, Nieto Y1, Champlin RE1, Hosing C1, Kebriaei P1.
Leukemia & lymphoma.Leuk Lymphoma.2017 Feb;58(2):366-371. Epub 2016 Jun 27.
Lymphoblastic lymphoma (LBL) is an aggressive lymphoma pathologically similar to lymphoblastic leukemia, but primarily presents with nodal or extra-medullary involvement. The aim of this study is to describe outcomes of patients undergoing stem cell transplantation (SCT) for LBL compared to historic
PMID 27348707

Cord blood chimerism and relapse after haplo-cord transplantation.

van Besien K1, Koshy N1, Gergis U1, Mayer S1, Cushing M2, Rennert H2, Reich-Slotky R2, Mark T1, Pearse R1, Rossi A1, Phillips A1, Vasovic L2, Ferrante R1, Hsu YM2, Shore T1.
Leukemia & lymphoma.Leuk Lymphoma.2017 Feb;58(2):288-297. Epub 2016 Jun 23.
Haplo-cord stem cell transplantation combines the infusion of CD34 selected hematopoietic progenitors from a haplo-identical donor with an umbilical cord blood (UCB) graft from an unrelated donor and allows faster count recovery, with low rates of disease recurrence and chronic graft-versus-host dis
PMID 27333804

Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.

Umino K1, Fujiwara SI1, Ito S1, Mashima K1, Minakata D1, Nakano H1, Yamasaki R1, Kawasaki Y1, Sugimoto M1, Ashizawa M1, Hatano K1, Okazuka K1, Sato K1, Oh I1, Ohmine K1, Suzuki T1, Muroi K1, Kanda Y1.
Leukemia & lymphoma.Leuk Lymphoma.2017 Feb;58(2):316-323. Epub 2016 Jun 7.
We evaluated 121 patients with follicular lymphoma (FL) and analyzed the association between the soluble interleukin-2 receptor (sIL-2R) level at diagnosis and the cumulative incidence of transformation. By a receiver-operating characteristic analysis, we determined a cutoff value of sIL-2R for tran
PMID 27267694

Japanese Journal

Evidence of surgical outcomes fluctuates over time: Results from a cumulative meta-analysis of laparoscopic versus open appendectomy for acute appendicitis

BMC Gastroenterology 16, 2016-03-15
NAID 120005758294

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients

Acta Medica Okayama 70(1), 1-12, 2016-02
NAID 120005712600

Association between shelter crowding and incidence of sleep disturbance among disaster evacuees: A retrospective medical chart review study

BMJ Open 6(1), 2016-01-13
NAID 120005820890

Related Pictures

★リンクテーブル★

拡張検索	「cumulative incidence ratio」
関連記事	「incidence」「cumulative」

「cumulative incidence ratio」

　　[★] 累積発生比、累積罹患比

「incidence」

　　[★]

n.

(できごと・影響などの)範囲、発生/発生率、発病率、影響/作用を及ぼすこと。付随的であること。負担、帰着
(投射物・光線などの)落下/入射/投射。(数学)結合(直線とそれを含む平面などの部分的一致)。(光・理)投射/入射(角)
(疫学)罹患率

「cumulative」

　　[★]

adj.

累積的な、累積の、累積性の

関: accumulate、accumulation、accumulative、accumulatively、cumulatively

[1] Rychetnik L, Hawe P, Waters E, Barratt A, Frommer M (July 2004). "A glossary for evidence based public health". J Epidemiol Community Health. 58 (7): 538–45. doi:10.1136/jech.2003.011585. PMC 1732833. PMID 15194712.

[2] Dodge, Y. (2003). The Oxford Dictionary of Statistical Terms. OUP. ISBN 0-19-920613-9.

[Bouyer2009-3] Bouyer, Jean; Hémon, Denis; Cordier, Sylvaine; Derriennic, Francis; Stücker, Isabelle; Stengel, Bénédicte; Clavel, Jacqueline (2009). Épidemiologie principes et méthodes quantitatives. Paris: Lavoisier.

v t e Clinical research and experimental design

Overview	Clinical trial Trial protocols Adaptive clinical trial Academic clinical trials Clinical study design

Controlled study (EBM I to II-1; A to B)	Randomized controlled trial Scientific experiment Blind experiment Open-label trial

Observational study (EBM II-2 to II-3; B to C)	Cross-sectional study vs. Longitudinal study, Ecological study Cohort study Retrospective Prospective Case-control study (Nested case-control study) Case series Case study Case report

Epidemiology/ methods	occurrence: Incidence (Cumulative incidence) Prevalence Point Period association: absolute (Absolute risk reduction, Attributable risk, Attributable risk percent) relative (Relative risk, Odds ratio, Hazard ratio) other: Clinical endpoint Virulence Infectivity Mortality rate Morbidity Case fatality rate Specificity and sensitivity Likelihood-ratios Pre/post-test probability

Trial/test types	In vitro In vivo Animal testing Animal testing on non-human primates First-in-man study Multicenter trial Seeding trial Vaccine trial

Analysis of clinical trials	Risk–benefit ratio Systematic review Replication Meta-analysis

Interpretation of results	Selection bias Survivorship bias Correlation does not imply causation Null result

Category Glossary List of topics

匿名

検索

案内

案内

cumulative incidence